969 / 1084
Oxaliplatin and capecitabine are noninferior to cisplatin and fluorouracil
, respectively,
with
perhaps a more manageable toxicity profile
, and both of these agents are now
established in combination chemotherapy regimens for metastatic disease
03/28/2017